- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 8th, 2007
A study by Marks & Clerk, an intellectual property firm based in the United Kingdom, has found that during the period between 2002 and 2006, universities like UCSF and public research institutes, rather than private companies, drove advances in biotechnology.
The results of the study, released at the BIO conference in Boston, were reported in the Monday, May 7, 2007, edition of the Financial Times.
• Among US and Canadian universities, the University of California system is runner-up behind MIT in turning knowledge into commercially viable products and start-up companies.
• UC ranked first for numbers of US biotech patents issued, with 723 patents between 2000 and 2004.
• UC produces the second-highest number of start-up businesses, approximately 20 a year.
• Three UC campuses are in the top 10 rankings worldwide as measured by research publications, US patents issued and the commercial impact of the discoveries. They are UCSF (4th), UC San Diego (6th) and UCLA (10th). Harvard University is No. 1 based on the three performance indicators.
• One out of every five nanotech patents comes from the UC system.
|Related News Press|
COD Grad Begins Postdoctoral Fellow at Harvard University: Marsela Jorgolli's Passion for Physics Has Led to a Decade of Academic Research That Continues at Harvard University as a Postdoctoral Fellow February 2nd, 2016
BioSolar Extends Research Agreement With UCSB for Next Phase of Its Super Battery Technology: Development Effort to Continue Under the Supervision of Nobel Laureate, Dr. Alan Heeger January 13th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016
Canadian physicists discover new properties of superconductivity February 8th, 2016
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
From allergens to anodes: Pollen derived battery electrodes February 8th, 2016
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016